Skip to main content
eScholarship
Open Access Publications from the University of California

Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: A randomized controlled trial

  • Author(s): Herold, KC
  • Gitelman, SE
  • Willi, SM
  • Gottlieb, PA
  • Waldron-Lynch, F
  • Devine, L
  • Sherr, J
  • Rosenthal, SM
  • Adi, S
  • Jalaludin, MY
  • Michels, AW
  • Dziura, J
  • Bluestone, JA
  • et al.
Main Content
Current View